Electronic Health Record Strategies to Promote Diverse Participation in Research
NCT ID: NCT05348603
Last Updated: 2023-12-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
726199 participants
INTERVENTIONAL
2022-09-13
2023-11-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The secondary objective is to examine the effectiveness of two enhanced online patient portal features including banners, a chatbot and direct-to-patient messages and traditional mailed letters on increasing participation in research among online patient portal users, as measured by the user joining a research study.
This study tests the hypothesis that at one year follow-up, various user engagement tools (e.g. messaging, banners) will increase the proportion of research profiles created by online patient portal users over profiles created by online patient portal users in the absence of those interventions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No Intervention
\*No intervention.
No interventions assigned to this group
Traditional Letter Only
\*A mailed letter will invite the patient to set up a research profile in their patient portal.
Traditional Letter
Patients receive a traditional letter.
Direct to Patient Message Only
\*An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research.
Direct to Patient Message
Patients receive a direct to patient message via the portal.
Chatbot Only
\*A real-time, interactive chatbot on the patient portal will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests.
Chatbot
Patients are contacted by a chatbot via the portal.
Banner Only
\*Banner-type "advertisements" will appear during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Banner
Patients are exposed to a banner ad via the portal.
Traditional Letter + Direct to Patient Message
* A mailed letter will invite the patient to set up a research profile in their patient portal; AND
* An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research.
Traditional Letter
Patients receive a traditional letter.
Direct to Patient Message
Patients receive a direct to patient message via the portal.
Traditional Letter + Chatbot
* A mailed letter will invite the patient to set up a research profile in their patient portal; AND
* A real-time, interactive chatbot will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests.
Traditional Letter
Patients receive a traditional letter.
Chatbot
Patients are contacted by a chatbot via the portal.
Traditional Letter + Banner
* A mailed letter will invite the patient to set up a research profile in their patient portal; AND
* Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Traditional Letter
Patients receive a traditional letter.
Banner
Patients are exposed to a banner ad via the portal.
Direct to Patient Message + Chatbot
* An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research; AND
* A real-time, interactive chatbot will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests.
Direct to Patient Message
Patients receive a direct to patient message via the portal.
Chatbot
Patients are contacted by a chatbot via the portal.
Direct to Patient Message + Banner
* An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research AND
* Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Direct to Patient Message
Patients receive a direct to patient message via the portal.
Banner
Patients are exposed to a banner ad via the portal.
Chatbot + Banner
* A real-time, interactive chatbot will encourage research participation and direct patients to learn more about clinical trial opportunities and trials that match their interests; AND
* Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care will inform patients of research opportunities.
Chatbot
Patients are contacted by a chatbot via the portal.
Banner
Patients are exposed to a banner ad via the portal.
Traditional Letter + Direct to Patient Message + Chatbot
* A mailed letter will invite the patient to set up a research profile in their patient portal; AND
* An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research; AND
* A real-time, interactive chatbot will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests.
Traditional Letter
Patients receive a traditional letter.
Direct to Patient Message
Patients receive a direct to patient message via the portal.
Chatbot
Patients are contacted by a chatbot via the portal.
Traditional Letter + Direct to Patient Message + Banner
* A mailed letter will invite the patient to set up a research profile in their patient portal; AND
* An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research; AND
* Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Traditional Letter
Patients receive a traditional letter.
Direct to Patient Message
Patients receive a direct to patient message via the portal.
Banner
Patients are exposed to a banner ad via the portal.
Traditional Letter + Chatbot + Banner
* A mailed letter will invite the patient to set up a research profile in their patient portal; AND
* A real-time, interactive chatbot will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests.
AND
\*Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Traditional Letter
Patients receive a traditional letter.
Chatbot
Patients are contacted by a chatbot via the portal.
Banner
Patients are exposed to a banner ad via the portal.
Direct to Patient Message + Chatbot + Banner
* An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research; AND
* A real-time, interactive chatbot will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests; AND
* Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Direct to Patient Message
Patients receive a direct to patient message via the portal.
Chatbot
Patients are contacted by a chatbot via the portal.
Banner
Patients are exposed to a banner ad via the portal.
Traditional Letter + Direct to Patient Message + Chatbot + Banner
* A mailed letter will invite the patient to set up a research profile in their patient portal; AND
* An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research; AND
* A real-time, interactive chatbot will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests; AND
* Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Traditional Letter
Patients receive a traditional letter.
Direct to Patient Message
Patients receive a direct to patient message via the portal.
Chatbot
Patients are contacted by a chatbot via the portal.
Banner
Patients are exposed to a banner ad via the portal.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Traditional Letter
Patients receive a traditional letter.
Direct to Patient Message
Patients receive a direct to patient message via the portal.
Chatbot
Patients are contacted by a chatbot via the portal.
Banner
Patients are exposed to a banner ad via the portal.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has logged into the online patient portal at least once in the past year
* Has not set up a research profile
Exclusion Criteria
* Opted out of research
* Has received a direct to patient recruitment message within the past year
* On active cancer treatment
* Active member of the study team
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Food and Drug Administration (FDA)
FED
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brian Smith, MD
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale University
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
75F40120C00174
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2000032716
Identifier Type: -
Identifier Source: org_study_id